DK10191D0 - Hidtil ukendte peptider - Google Patents

Hidtil ukendte peptider

Info

Publication number
DK10191D0
DK10191D0 DK010191A DK10191A DK10191D0 DK 10191 D0 DK10191 D0 DK 10191D0 DK 010191 A DK010191 A DK 010191A DK 10191 A DK10191 A DK 10191A DK 10191 D0 DK10191 D0 DK 10191D0
Authority
DK
Denmark
Prior art keywords
molecule
insulin
human insulin
unknown peptides
insulin analogues
Prior art date
Application number
DK010191A
Other languages
Danish (da)
English (en)
Inventor
Jens Joergen Veilgaard Brange
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK010191A priority Critical patent/DK10191D0/da
Publication of DK10191D0 publication Critical patent/DK10191D0/da
Priority to PCT/DK1992/000019 priority patent/WO1992012999A1/en
Priority to JP4503787A priority patent/JPH06506444A/ja
Priority to AU11902/92A priority patent/AU1190292A/en
Priority to DE69210011T priority patent/DE69210011T2/de
Priority to CA002100565A priority patent/CA2100565A1/en
Priority to AT92903864T priority patent/ATE136907T1/de
Priority to EP92903864A priority patent/EP0568594B1/de
Priority to US08/301,838 priority patent/US5597796A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK010191A 1991-01-22 1991-01-22 Hidtil ukendte peptider DK10191D0 (da)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DK010191A DK10191D0 (da) 1991-01-22 1991-01-22 Hidtil ukendte peptider
PCT/DK1992/000019 WO1992012999A1 (en) 1991-01-22 1992-01-22 Novel insulin analogs
JP4503787A JPH06506444A (ja) 1991-01-22 1992-01-22 新規インスリン類似体
AU11902/92A AU1190292A (en) 1991-01-22 1992-01-22 Novel insulin analogs
DE69210011T DE69210011T2 (de) 1991-01-22 1992-01-22 Neue Insulinanaloge geeignet für die transdermale Anwendung
CA002100565A CA2100565A1 (en) 1991-01-22 1992-01-22 Insulin analogs
AT92903864T ATE136907T1 (de) 1991-01-22 1992-01-22 Neue insulinanaloge geeignet für die transdermale anwendung
EP92903864A EP0568594B1 (de) 1991-01-22 1992-01-22 Neue Insulinanaloge geeignet für die transdermale Anwendung
US08/301,838 US5597796A (en) 1991-01-22 1994-09-07 Transdermal insulin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK010191A DK10191D0 (da) 1991-01-22 1991-01-22 Hidtil ukendte peptider

Publications (1)

Publication Number Publication Date
DK10191D0 true DK10191D0 (da) 1991-01-22

Family

ID=8089747

Family Applications (1)

Application Number Title Priority Date Filing Date
DK010191A DK10191D0 (da) 1991-01-22 1991-01-22 Hidtil ukendte peptider

Country Status (9)

Country Link
US (1) US5597796A (de)
EP (1) EP0568594B1 (de)
JP (1) JPH06506444A (de)
AT (1) ATE136907T1 (de)
AU (1) AU1190292A (de)
CA (1) CA2100565A1 (de)
DE (1) DE69210011T2 (de)
DK (1) DK10191D0 (de)
WO (1) WO1992012999A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2087087C (en) * 1992-01-22 2000-07-18 Burton H. Sage, Jr. Molecules for iontophoretic delivery
US5747453A (en) 1995-06-06 1998-05-05 Alza Corporation Method for increasing the electrotransport flux of polypeptides
IT1285405B1 (it) 1995-06-06 1998-06-03 Alza Corp Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto.
CA2236579C (en) * 1995-11-13 2009-06-30 Minimed, Inc. Methods and compositions for the delivery of monomeric proteins
US6333189B1 (en) 1996-06-06 2001-12-25 Alza Corporation Method of making an electrotransport device
US5857994A (en) * 1996-10-01 1999-01-12 Becton, Dickinson And Company Awakenable iontophoretic/delivery device for reducing electrical sensation upon application thereof
DE19726167B4 (de) * 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
CN1278737A (zh) * 1997-11-12 2001-01-03 阿尔萨公司 减少多肽自结合的方法
US6562942B1 (en) * 1999-02-23 2003-05-13 Neurocrine Biosciences, Inc. Methods for treatment of diabetes using peptide analogues of insulin
US6406455B1 (en) * 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
CA2362814A1 (en) * 1999-02-18 2000-08-24 Biovalve Technologies, Inc. Electroactive pore
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
NZ519403A (en) * 2001-06-21 2005-03-24 Pfizer Prod Inc Use of insulin in a medicament to reduce weight gain in a diabetic patient who is using exogenous insulin to control blood sugar levels
JP4033382B2 (ja) * 2002-04-08 2008-01-16 久光製薬株式会社 インスリン投与装置
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
US20090069216A1 (en) * 2006-02-21 2009-03-12 Novo Nordisk A/S Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof
EP2024390B1 (de) * 2006-05-09 2015-08-19 Novo Nordisk A/S Insulinderivate
ES2395738T3 (es) 2006-05-09 2013-02-14 Novo Nordisk A/S Derivado de insulina
ES2542146T3 (es) 2006-07-31 2015-07-31 Novo Nordisk A/S Insulinas extendidas PEGiladas.
CN101541830A (zh) 2006-09-22 2009-09-23 诺沃-诺迪斯克有限公司 蛋白酶抗性的胰岛素类似物
EP2152245B1 (de) 2007-04-30 2015-12-02 Novo Nordisk A/S Verfahren zum Trocknen einer Proteinzusammensetzung, getrocknete Proteinzusammensetzung und pharmazeutische Zusammensetzungen mit dem getrockneten Protein
JP2009067766A (ja) * 2007-09-12 2009-04-02 Kosumedei Seiyaku Kk 経皮吸収促製剤及びそれを用いた経皮吸収システム
DK2229407T3 (en) * 2008-01-09 2017-02-27 Sanofi Aventis Deutschland NEW INSULIN DERIVATIVES WITH EXTREMELY DELAYED TIME / EFFECTS PROFILE
EP2229406B1 (de) * 2008-01-09 2015-04-22 Sanofi-Aventis Deutschland GmbH Neue insulinderivate mit extrem verzögertem zeit- / wirkungsprofil
US9260502B2 (en) 2008-03-14 2016-02-16 Novo Nordisk A/S Protease-stabilized insulin analogues
RU2571857C2 (ru) 2008-03-18 2015-12-20 Ново Нордиск А/С Стабилизированные по отношению к протеазам ацилированные аналоги инсулина
MX349717B (es) 2008-10-17 2017-08-09 Sanofi Aventis Deutschland Combinación de una insulina y un agonista de glp-1.
EP2451472A1 (de) * 2009-07-06 2012-05-16 Sanofi-Aventis Deutschland GmbH Hitze- und schüttelstabile insulinzubereitungen
TR201809460T4 (tr) 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
HUE037735T2 (hu) 2009-11-13 2018-09-28 Sanofi Aventis Deutschland DesPro36exendin-4(1-39)-Lys6-NH2-t és metionint tartalmazó gyógyszerkészítmény
CA2796567C (en) 2010-03-31 2016-07-12 Wockhardt Limited Composition comprising insulin and herbal oil for transdermal or transmucosal administration
SI2611458T1 (sl) 2010-08-30 2017-01-31 Sanofi-Aventis Deutschland Gmbh Uporaba AVE0010 za izdelavo zdravila za zdravljenje sladkorne bolezni tipa 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
RU2650616C2 (ru) 2011-08-29 2018-04-16 Санофи-Авентис Дойчланд Гмбх Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
JP2015507916A (ja) * 2012-01-20 2015-03-16 ケース ウェスタン リザーブ ユニバーシティＣａｓｅ Ｗｅｓｔｅｒｎｒｅｓｅｒｖｅ Ｕｎｉｖｅｒｓｉｔｙ グルタミン酸安定化インスリン類似体
CA2870313A1 (en) 2012-04-11 2013-10-17 Novo Nordisk A/S Insulin formulations
CA2942524A1 (en) * 2013-03-15 2014-09-18 Case Western Reserve University Site 2 insulin analogues
HUE036702T2 (hu) 2013-10-07 2018-07-30 Novo Nordisk As Inzulinanalóg új származéka
GB201321489D0 (en) 2013-12-05 2014-01-22 Chemical & Biopharmaceutical Lab Of Patras S A Biologically active insulin derivatives
SI3229828T1 (sl) 2014-12-12 2023-06-30 Sanofi-Aventis Deutschland Gmbh Formulacija s fiksnim razmerjem inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
KR20190043609A (ko) 2016-09-06 2019-04-26 케미컬 앤드 바이오파마슈티컬 라보라토리즈 오브 파트라스 에스.에이. 프로인슐린 유도체
TWI700091B (zh) 2016-12-16 2020-08-01 丹麥商諾佛 儂迪克股份有限公司 含胰島素醫藥組成物
WO2019034726A1 (en) 2017-08-17 2019-02-21 Novo Nordisk A/S NOVEL ACYLATED INSULIN ANALOGUES AND USES THEREOF
EP3756679A1 (de) 2019-06-28 2020-12-30 Université de Genève Zusammensetzungen zur verwendung in der behandlung von insulinmangelstörungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK257988D0 (da) * 1988-05-11 1988-05-11 Novo Industri As Nye peptider
JPH03506023A (ja) * 1988-07-20 1991-12-26 ノボ　ノルデイスク　アクツイエセルスカプ ポリペプチド
HUT56857A (en) * 1988-12-23 1991-10-28 Novo Nordisk As Human insulin analogues
US5514646A (en) * 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
IL93282A (en) * 1989-02-09 1995-08-31 Lilly Co Eli Insulin analogues

Also Published As

Publication number Publication date
AU1190292A (en) 1992-08-27
JPH06506444A (ja) 1994-07-21
CA2100565A1 (en) 1992-07-23
US5597796A (en) 1997-01-28
EP0568594A1 (de) 1993-11-10
EP0568594B1 (de) 1996-04-17
ATE136907T1 (de) 1996-05-15
DE69210011D1 (de) 1996-05-23
DE69210011T2 (de) 1996-09-05
WO1992012999A1 (en) 1992-08-06

Similar Documents

Publication Publication Date Title
DK10191D0 (da) Hidtil ukendte peptider
ATA260690A (de) Therapeutische infusionszubereitung auf basis von aminosäurederivaten
ATE73459T1 (de) Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten.
DE3676670D1 (de) Solubilisierung von proteinen fuer pharmazeutische zusammensetzungen mittels polymerkonjugierung.
ATE63813T1 (de) Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren.
ES2001624A6 (es) Un metodo para preparar compuestos analogos a insulina humana de accion rapida
ATE77391T1 (de) Peptide.
DK0439042T3 (da) Anvendelse af farmaceutiske og kosmetiske præparater med blandingsmiceller
DE3772521D1 (de) Insulinzubereitung fuer nicht-parenterale verabreichung.
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
NZ294743A (en) A formulation for administering transdermally a protein or polypeptide such as insulin
EP1234586A3 (de) Selektiv auf der Leber wierkenden Pharmaka
LV10720A (lv) Peptidi un farmaceitiska kompozicija uz to bazes
FI893783A (fi) Menetelmä diabetes mellituksen hoitoon tarkoitetun farmaseuttisen valmisteen valmistamiseksi
DK414389D0 (da) Farmaceutisk praeparat indeholdende et aminosyrederivat med renin-inhibitorisk virkning
DK395789A (da) Anvendelse af alfa-aminoboronsyrederivater til fremstilling af et laegemiddel til terapi eller profylakse af virussygdomme
ATE125706T1 (de) Diphosphonate enthaltende pharmazeutische zusammensetzungen zur behandlung von arthrosis.
DE69004532T2 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
FI893681A (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
DK288789A (da) Peptider og syreadditionssalte deraf, deres fremstilling og anvendelse
GR3003733T3 (de)
PT88539A (pt) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
NO890174L (no) Rekombinante interleukin-1alfa-polypeptider.
AU1318797A (en) Peptides and uses thereof for therapy of celiac diseases
PT789761E (pt) Scf humano, uma respectiva variante de processamento, sua utilizacao farmaceutica

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment